Table 1.
Electrotransformant in E. coli DH10B T1R | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Antimicrobial agents | A. hydrophila GSH8‐2 | A. caviae GSH8M‐1 | ‐ | pGSH8‐2 | pGSH8M‐1‐2 | |||||
AMS | 128 | R | 128 | R | 1.5 | S | 128 | R | 48 | R |
CEP | 4 | I | 16 | R | 0.032 | S | 0.75 | S | 0.75 | S |
CTA | 32 | R | >32 | R | 0.032 | S | 1.5 | I | 0.75 | I |
CTZ | 2 | I | 16 | R | 0.032 | S | 2 | I | 1.5 | I |
IMI | 1 | S | 4 | I | 0.19 | S | 1 | S | 0.75 | S |
MER | 1 | S | 4 | I | ≤0.125 | S | 0.19 | S | 0.125 | S |
AZT | 8 | R | 32 | R | 0.064 | S | 12 | R | 12 | R |
AMI | 2 | S | 16 | I | 1 | S | 1.5 | S | 1.5 | S |
GEN | 0.5 | S | 1 | S | 0.38 | S | 0.38 | S | 0.5 | S |
TOB | 2 | S | 8 | R | 0.25 | S | 0.25 | S | 0.38 | S |
TET | 8 | ‐ | 2 | ‐ | 0.75 | ‐ | 1 | ‐ | 1 | ‐ |
CIP | 0.5 | I | 1 | R | ≤0.002 | S | ≤0.002 | S | ≤0.002 | S |
LEV | 2 | R | 2 | R | 0.004 | S | 0.004 | S | 0.004 | S |
AZI | 64 | ‐ | 32 | ‐ | 2 | ‐ | 3 | ‐ | 96 | ‐ |
TRS | 0.25 | S | 1 | S | 0.016 | S | 0.023 | S | 0.023 | S |
CHL | 1 | S | 2 | S | 1.5 | S | 1.5 | S | 1.5 | S |
COL | 2 | S | 0.5 | S | 0.032 | S | 0.047 | S | 0.047 | S |
AMS, ampicillin‐sulbactam; CEP, cefepime; CTA, cefotaxime; CTZ, ceftazidime; IMI, imipenem; MER, meropenem; AZT, aztreonam; AMI, amikacin; GEN, gentamicin; TOB, tobramycin; TET, tetracycline; CIP, ciprofloxacin; LEV, levofloxacin; AZI, azithromycin; TRS, trimethoprim‐sulfamethoxazole; CHL, chloramphenicol; COL, colistin.
‐, not defined in EUCAST.